What Is the Stop Drinking Pill?
A cautious answer to the stop-drinking-pill question that stays educational, clinician-routed, and free of dosing, access, or best-medication claims.
Type "the stop drinking pill" into a search bar and it sounds like one object: a single tablet that quietly switches off the wanting. There isn't one. What exists instead is a small set of prescription medicines — three of them approved by the U.S. Food and Drug Administration for alcohol use disorder — and they don't do the same job. One turns down the pleasure a drink gives you. One steadies a brain that stays restless after you quit. One makes drinking physically unpleasant. Understanding which is which is the actual answer to the question, because the differences decide which one, if any, would ever make sense for a given person.
Three medicines, three different jobs
Naltrexone is the one most people picture when they imagine a craving pill. A drink nudges the brain's own feel-good chemistry — the endorphin system — and that nudge is part of the lift alcohol gives. Naltrexone parks itself on the receptors those endorphins would otherwise use and blocks them. The American Academy of Family Physicians explains that opioid receptors likely help mediate the pleasant effects of alcohol, so blocking them takes some of the reward out of a drink. SAMHSA describes the practical result the same way: naltrexone reduces alcohol cravings and the amount a person drinks. Its FDA label lists it for the treatment of alcohol dependence. Because it acts on opioid receptors, it is off-limits for anyone taking opioid pain medicine or dependent on opioids — an important reason it is a clinician's call, not a self-serve one.
Acamprosate works on a different problem entirely. Heavy drinking over months or years pushes the brain's "go" and "calm down" signals out of balance, and quitting doesn't reset that overnight — the imbalance lingers, which is part of why early sobriety can feel raw and on edge. Acamprosate is described in the pharmacology literature as acting on that over-revved "go" system (the glutamate system) to help it settle back toward normal. That is why it is approved to help people who have already stopped stay stopped, rather than to help someone cut down while still drinking.
Disulfiram, sold as Antabuse, doesn't touch cravings at all. Your body normally breaks alcohol down in two steps; disulfiram blocks the second step, so a toxic byproduct called acetaldehyde piles up when you drink. The result is flushing, a pounding head, and nausea — a deliberate deterrent, a tripwire rather than a craving-easer. Its own label is blunt that it is an aid for someone who wants to stay in a state of enforced sobriety, not a cure. A peer-reviewed overview lines the three up neatly: disulfiram makes drinking feel awful, naltrexone makes drinking feel less rewarding, and acamprosate calms the after-quitting jitters. Three tools, three jobs.
What the evidence says, and where it stops
None of the three is a magic switch, and the evidence is honest about that. The Agency for Healthcare Research and Quality's review of the trials found that naltrexone and acamprosate each carried moderate-strength evidence for reducing a return to drinking, while disulfiram had inadequate evidence against a placebo. That is why guidance from bodies like the AAFP tends to treat naltrexone and acamprosate as the better-supported first options, with disulfiram reserved for specific situations. The same guidance is consistent on one more point: medication works best paired with some kind of behavioral support, not used alone. What the evidence cannot do is tell you which one fits your history, your goal, and your other medicines. That match is a clinical judgment, not a search result.
There is also a gap worth stating plainly. In 2024, an estimated 27.9 million people ages 12 and older in the United States had past-year alcohol use disorder — about 9.7% of that age group. That same year, only about 2.1 million of them, roughly 7.6%, received any alcohol-use treatment, and the share who were offered a medication was smaller still. Most people who could be candidates are simply never told these medicines exist. That is a gap in access and awareness, not a sign the medicines fail — and it means that reading this at all puts you ahead of the usual curve.
"To quit" or "to cut back" is the more useful question
Here is the distinction the "one pill" framing hides, and it is probably the thing you actually want to know: the three medicines assume you are at different points. Naltrexone can be taken while a person is still drinking and is studied as a way to reduce drinking, so it fits someone whose goal is to cut back or who hasn't stopped yet. Acamprosate is built for after you have already quit — it is a stay-stopped medicine, not a cut-down one. Disulfiram only works as a deterrent if you are committed to not drinking at all, because drinking on it is the unpleasant part. So the honest first question is rarely "which pill." It is "what is my goal — cut back or stop — and where am I right now, still drinking or already dry?" Answer that, and the field of options narrows on its own. Bring the "which pill" version to a clinician and you are handing them the hardest question first; bring the "here is my goal and my history" version and you are handing them the one they can actually work with.
If you're weighing this seriously
A clinician deciding about any of these will want a real picture: how much and how often you drink, whether you have already stopped, what other medicines you take (opioids especially), your liver and kidney history, your mental health, and what support you have. Those aren't hoops — they are how the decision gets made safely. If the idea interests you but you don't have anyone to raise it with, Clero connects you with a licensed clinician by telehealth who can look at your history and talk through whether a medicine like naltrexone fits your situation.
One safety point sits above all of this. If your drinking is heavy or daily, stopping abruptly can be genuinely dangerous — none of these pills is a way to get through withdrawal, and none should be treated as one. If a stretch without alcohol has ever brought on shaking, sweating, confusion, hallucinations, or a seizure, that is a medical emergency: call 911 or go to an emergency room, per MedlinePlus's withdrawal guidance. The plan to stop safely comes before any long-term-medication plan.
FAQ
Which medicine do people usually mean by "the stop drinking pill"?
Most often naltrexone or disulfiram (Antabuse), and they are opposites in spirit. Naltrexone quietly turns down the reward of a drink so it feels less worth it; disulfiram makes drinking physically unpleasant so you don't want to risk it. Acamprosate is the third approved option and is aimed at staying stopped after you've quit.
Is there a pill that makes you sick if you drink?
Yes — that is disulfiram. It lets a byproduct of alcohol build up in your body, so drinking on it causes flushing, nausea, and a bad headache. It only helps people who intend to stay off alcohol entirely, and it is not a cure for the underlying problem.
Can you take one of these while you're still drinking?
It depends which. Naltrexone can be started while someone is still drinking and is studied for cutting down. Acamprosate is meant for after you've already stopped, and disulfiram only makes sense if you plan not to drink at all. That is exactly why the goal-and-timing question matters more than the "which pill" one.
This article is general education — not medical advice, a dosing guide, or a prescription. Any decision about medication belongs with a licensed clinician who knows your history. If you feel unsafe with yourself, call or text 988; for treatment referrals, SAMHSA's National Helpline is 1-800-662-HELP.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.